APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Diagnosis & Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global HIV Diagnosis & Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025188 pages

Choose your research edition.

Industry ResearchHIV Diagnosis & Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Diagnosis & Treatment Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal HIV Diagnosis & Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Diagnosis & Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Diagnosis & Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global HIV Diagnosis & Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for HIV Diagnosis & Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HIV Diagnosis & Treatment include Abbott Laboratories, Johnson & Johnson, GlaxoSmithKline, Gilead, F. Hoffmann-La Roche, Cipla, Bristol-Myers Squibb and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global HIV Diagnosis & Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of HIV Diagnosis & Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents HIV Diagnosis & Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the HIV Diagnosis & Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

HIV Diagnosis & Treatment Segment by Company

Abbott Laboratories

Johnson & Johnson

GlaxoSmithKline

Gilead

F. Hoffmann-La Roche

Cipla

Bristol-Myers Squibb

Boehringer Ingelheim

HIV Diagnosis & Treatment Segment by Type

Saliva Tests

ELISA Test

Western Blot

Viral Load Test

Others

HIV Diagnosis & Treatment Segment by Application

Hospitals

Clinics

HIV Diagnosis & Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Diagnosis & Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Diagnosis & Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Diagnosis & Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of HIV Diagnosis & Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global HIV Diagnosis & Treatment industry.

Chapter 3: Detailed analysis of HIV Diagnosis & Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Diagnosis & Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Saliva Tests Table 3. Key Players of ELISA Test Table 4. Key Players of Western Blot Table 3. Key Players of Viral Load Test Table 4. Key Players of Others Table 5. Global HIV Diagnosis & Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Clinics Table 8. Global HIV Diagnosis & Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global HIV Diagnosis & Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global HIV Diagnosis & Treatment Market Share by Region (2021-2026) Table 11. Global HIV Diagnosis & Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global HIV Diagnosis & Treatment Market Share by Region (2027-2032) Table 13. HIV Diagnosis & Treatment Industry Trends Table 14. HIV Diagnosis & Treatment Industry Drivers Table 15. HIV Diagnosis & Treatment Industry Opportunities and Challenges Table 16. HIV Diagnosis & Treatment Industry Restraints Table 17. Global HIV Diagnosis & Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global HIV Diagnosis & Treatment Revenue Market Share by Company (2021-2026) Table 19. Global HIV Diagnosis & Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global HIV Diagnosis & Treatment Key Company Head Office and Area Served Table 21. Global HIV Diagnosis & Treatment Company, Product Type & Application Table 22. Global HIV Diagnosis & Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global HIV Diagnosis & Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global HIV Diagnosis & Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global HIV Diagnosis & Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2021-2026) Table 29. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2027-2032) Table 30. Global HIV Diagnosis & Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global HIV Diagnosis & Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2021-2026) Table 34. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2027-2032) Table 35. Abbott Laboratories Company Information Table 36. Abbott Laboratories Business Overview Table 37. Abbott Laboratories HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott Laboratories HIV Diagnosis & Treatment Product Portfolio Table 39. Abbott Laboratories Recent Development Table 40. Johnson & Johnson Company Information Table 41. Johnson & Johnson Business Overview Table 42. Johnson & Johnson HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Johnson & Johnson HIV Diagnosis & Treatment Product Portfolio Table 44. Johnson & Johnson Recent Development Table 45. GlaxoSmithKline Company Information Table 46. GlaxoSmithKline Business Overview Table 47. GlaxoSmithKline HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GlaxoSmithKline HIV Diagnosis & Treatment Product Portfolio Table 49. GlaxoSmithKline Recent Development Table 50. Gilead Company Information Table 51. Gilead Business Overview Table 52. Gilead HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Gilead HIV Diagnosis & Treatment Product Portfolio Table 54. Gilead Recent Development Table 55. F. Hoffmann-La Roche Company Information Table 56. F. Hoffmann-La Roche Business Overview Table 57. F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Portfolio Table 59. F. Hoffmann-La Roche Recent Development Table 60. Cipla Company Information Table 61. Cipla Business Overview Table 62. Cipla HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Cipla HIV Diagnosis & Treatment Product Portfolio Table 64. Cipla Recent Development Table 65. Bristol-Myers Squibb Company Information Table 66. Bristol-Myers Squibb Business Overview Table 67. Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Bristol-Myers Squibb HIV Diagnosis & Treatment Product Portfolio Table 69. Bristol-Myers Squibb Recent Development Table 70. Boehringer Ingelheim Company Information Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Boehringer Ingelheim HIV Diagnosis & Treatment Product Portfolio Table 74. Boehringer Ingelheim Recent Development Table 75. North America HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 76. North America HIV Diagnosis & Treatment Market Size by Type (2027-2032) & (US$ Million) Table 77. North America HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 78. North America HIV Diagnosis & Treatment Market Size by Application (2027-2032) & (US$ Million) Table 79. North America HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America HIV Diagnosis & Treatment Market Size by Country (2021-2026) Table 81. North America HIV Diagnosis & Treatment Market Size by Country (2027-2032) Table 82. Europe HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe HIV Diagnosis & Treatment Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe HIV Diagnosis & Treatment Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe HIV Diagnosis & Treatment Market Size by Country (2021-2026) Table 88. Europe HIV Diagnosis & Treatment Market Size by Country (2027-2032) Table 89. China HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 90. China HIV Diagnosis & Treatment Market Size by Type (2027-2032) & (US$ Million) Table 91. China HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 92. China HIV Diagnosis & Treatment Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia HIV Diagnosis & Treatment Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia HIV Diagnosis & Treatment Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia HIV Diagnosis & Treatment Market Size by Country (2021-2026) Table 99. Asia HIV Diagnosis & Treatment Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. HIV Diagnosis & Treatment Product Image Figure 2. Global HIV Diagnosis & Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global HIV Diagnosis & Treatment Market Share by Type: 2025 VS 2032 Figure 4. Saliva Tests Image Figure 5. ELISA Test Image Figure 6. Western Blot Image Figure 7. Viral Load Test Image Figure 8. Others Image Figure 9. Global HIV Diagnosis & Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global HIV Diagnosis & Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Global HIV Diagnosis & Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global HIV Diagnosis & Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global HIV Diagnosis & Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 HIV Diagnosis & Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global HIV Diagnosis & Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global HIV Diagnosis & Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global HIV Diagnosis & Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global HIV Diagnosis & Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America HIV Diagnosis & Treatment Market Share by Type (2021-2032) Figure 26. North America HIV Diagnosis & Treatment Market Share by Application (2021-2032) Figure 27. North America HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 28. United States HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe HIV Diagnosis & Treatment Market Share by Type (2021-2032) Figure 33. Europe HIV Diagnosis & Treatment Market Share by Application (2021-2032) Figure 34. Europe HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 35. Germany HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China HIV Diagnosis & Treatment Market Share by Type (2021-2032) Figure 43. China HIV Diagnosis & Treatment Market Share by Application (2021-2032) Figure 44. Asia HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia HIV Diagnosis & Treatment Market Share by Type (2021-2032) Figure 46. Asia HIV Diagnosis & Treatment Market Share by Application (2021-2032) Figure 47. Asia HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 48. Japan HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa HIV Diagnosis & Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa HIV Diagnosis & Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa HIV Diagnosis & Treatment Market Share by Country (2021-2032) Figure 58. Brazil HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile HIV Diagnosis & Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Saliva Tests
  • ELISA Test
  • Western Blot
  • Viral Load Test
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Abbott Laboratories
  • Johnson & Johnson
  • GlaxoSmithKline
  • Gilead
  • F. Hoffmann-La Roche
  • Cipla
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global HIV Diagnosis & Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Saliva Tests
  5. 1.2.3 ELISA Test
  6. 1.2.4 Western Blot
  7. 1.2.5 Viral Load Test
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global HIV Diagnosis & Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global HIV Diagnosis & Treatment Growth Trends by Region
  15. 1.5.1 Global HIV Diagnosis & Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 HIV Diagnosis & Treatment Market Size by Region (2021-2026)
  17. 1.5.3 HIV Diagnosis & Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global HIV Diagnosis & Treatment Market Dynamics
  1. 2.1 HIV Diagnosis & Treatment Industry Trends
  2. 2.2 HIV Diagnosis & Treatment Industry Drivers
  3. 2.3 HIV Diagnosis & Treatment Industry Opportunities and Challenges
  4. 2.4 HIV Diagnosis & Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global HIV Diagnosis & Treatment Revenue by Company (2021-2026)
  2. 3.2 Global HIV Diagnosis & Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global HIV Diagnosis & Treatment Key Company Head office and Area Served
  4. 3.4 Global HIV Diagnosis & Treatment Company, Product Type & Application
  5. 3.5 Global HIV Diagnosis & Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global HIV Diagnosis & Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 HIV Diagnosis & Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 HIV Diagnosis & Treatment Tier 1, Tier 2, and Tier 3
4 HIV Diagnosis & Treatment Market by Type
  1. 4.1 Global HIV Diagnosis & Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global HIV Diagnosis & Treatment Market Size by Type (2021-2032)
  3. 4.3 Global HIV Diagnosis & Treatment Market Size Share by Type (2021-2032)
5 HIV Diagnosis & Treatment Market by Application
  1. 5.1 Global HIV Diagnosis & Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global HIV Diagnosis & Treatment Market Size by Application (2021-2032)
  3. 5.3 Global HIV Diagnosis & Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Laboratories HIV Diagnosis & Treatment Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Johnson & Johnson HIV Diagnosis & Treatment Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GlaxoSmithKline HIV Diagnosis & Treatment Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Gilead
  20. 6.4.1 Gilead Company Information
  21. 6.4.2 Gilead Business Overview
  22. 6.4.3 Gilead HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Gilead HIV Diagnosis & Treatment Product Portfolio
  24. 6.4.5 Gilead Recent Developments
  25. 6.5 F. Hoffmann-La Roche
  26. 6.5.1 F. Hoffmann-La Roche Company Information
  27. 6.5.2 F. Hoffmann-La Roche Business Overview
  28. 6.5.3 F. Hoffmann-La Roche HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche HIV Diagnosis & Treatment Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cipla HIV Diagnosis & Treatment Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Bristol-Myers Squibb
  38. 6.7.1 Bristol-Myers Squibb Company Information
  39. 6.7.2 Bristol-Myers Squibb Business Overview
  40. 6.7.3 Bristol-Myers Squibb HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb HIV Diagnosis & Treatment Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim HIV Diagnosis & Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boehringer Ingelheim HIV Diagnosis & Treatment Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America HIV Diagnosis & Treatment Market Size (2021-2032)
  2. 7.2 North America HIV Diagnosis & Treatment Market Size by Type
  3. 7.2.1 North America HIV Diagnosis & Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America HIV Diagnosis & Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America HIV Diagnosis & Treatment Market Share by Type (2021-2032)
  6. 7.3 North America HIV Diagnosis & Treatment Market Size by Application
  7. 7.3.1 North America HIV Diagnosis & Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America HIV Diagnosis & Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America HIV Diagnosis & Treatment Market Share by Application (2021-2032)
  10. 7.4 North America HIV Diagnosis & Treatment Market Size by Country
  11. 7.4.1 North America HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America HIV Diagnosis & Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America HIV Diagnosis & Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe HIV Diagnosis & Treatment Market Size (2021-2032)
  2. 8.2 Europe HIV Diagnosis & Treatment Market Size by Type
  3. 8.2.1 Europe HIV Diagnosis & Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe HIV Diagnosis & Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe HIV Diagnosis & Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe HIV Diagnosis & Treatment Market Size by Application
  7. 8.3.1 Europe HIV Diagnosis & Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe HIV Diagnosis & Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe HIV Diagnosis & Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe HIV Diagnosis & Treatment Market Size by Country
  11. 8.4.1 Europe HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe HIV Diagnosis & Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe HIV Diagnosis & Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China HIV Diagnosis & Treatment Market Size (2021-2032)
  2. 9.2 China HIV Diagnosis & Treatment Market Size by Type
  3. 9.2.1 China HIV Diagnosis & Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China HIV Diagnosis & Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China HIV Diagnosis & Treatment Market Share by Type (2021-2032)
  6. 9.3 China HIV Diagnosis & Treatment Market Size by Application
  7. 9.3.1 China HIV Diagnosis & Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China HIV Diagnosis & Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China HIV Diagnosis & Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia HIV Diagnosis & Treatment Market Size (2021-2032)
  2. 10.2 Asia HIV Diagnosis & Treatment Market Size by Type
  3. 10.2.1 Asia HIV Diagnosis & Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia HIV Diagnosis & Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia HIV Diagnosis & Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia HIV Diagnosis & Treatment Market Size by Application
  7. 10.3.1 Asia HIV Diagnosis & Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia HIV Diagnosis & Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia HIV Diagnosis & Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia HIV Diagnosis & Treatment Market Size by Country
  11. 10.4.1 Asia HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia HIV Diagnosis & Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia HIV Diagnosis & Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa HIV Diagnosis & Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa HIV Diagnosis & Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa HIV Diagnosis & Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa HIV Diagnosis & Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst